治疗难治性食管静脉曲张出血的新技术——自膨式食管金属支架

肝脏 ›› 2021, Vol. 26 ›› Issue (12): 1308-1310.

治疗难治性食管静脉曲张出血的新技术——自膨式食管金属支架

杨柳, 杨长青

200065 上海同济大学附属同济医院消化科

收稿日期:2021-11-05 发布日期:2022-01-13
通讯作者: 杨长青,Email:cqyang@tongji.edu.cn
基金资助:
国家自然科学基金项目 (81670571,81820108006);上海市临床重点专科建设项目(SHSLCZDZK 06801),上海申康三年行动计划重大临床研究项目(SHDC2020CR2030B)

Received:2021-11-05 Published:2022-01-13

摘要/Abstract

摘要： 食管静脉曲张破裂出血(Esophageal varices bleeding,EVB)是肝硬化门静脉高压症的一种常见并发症,也是最严重的并发症,与显著的发病率和死亡率有关。目前的指南建议使用自膨式食管金属支架(esophageal self-expanding metallic stents, SEMS)等临时性“桥接”疗法,直到可以执行经颈静脉肝内门体分流术(TIPS)等确定的治疗方案。本文综述了近几年来SEMS在治疗难治性曲张静脉出血研究中的应用结果,为进一步的临床应用和研究提供参考依据。

关键词: 食管静脉曲张出血, 自膨式食管金属支架, 肝硬化, 门静脉高压

杨柳, 杨长青. 治疗难治性食管静脉曲张出血的新技术——自膨式食管金属支架[J]. 肝脏, 2021, 26(12): 1308-1310.

参考文献

[1] McCarty TR, Njei B. Self-expanding metal stents for acute refractory esophageal variceal bleeding: A systematic review and meta-analysis. Dig Endosc,2016,28:539-547.
[2] Triantos C, Kalafateli M. Endoscopic treatment of esophageal varices in patients with liver cirrhosis. World J Gastroenterol,2014,20:13015-13026.
[3] Pontone S, Giusto M, Filippini A, et al. Hemostasis in uncontrolled esophageal variceal bleeding by self-expanding metal stents: a systematic review. Gastroenterol Hepatol Bed Bench,2016,9:6-11.
[4] 徐小元, 丁惠国, 贾继东,等. 肝硬化门静脉高压食管胃静脉曲张出血的防治指南. 实用肝脏病杂志, 2016,19:641-656.
[5] Maru?i? M, Klemen?i? A, Troskot Peri? R, et al. Gastroesophageal variceal bleeding-An overview of current treatment options. Acta Gastroenterol Belg,2018,81:305-317.
[6] Shao XD, Qi XS, Guo XZ. Esophageal Stent for Refractory Variceal Bleeding: A Systemic Review and Meta-Analysis. Biomed Res Int,2016,2016:4054513.
[7] Reverter E, Tandon P, Augustin S, et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology,2014,146:412-19.e3.
[8] Rodrigues SG, Cárdenas A, Escorsell ?, et al. Balloon Tamponade and Esophageal Stenting for Esophageal Variceal Bleeding in Cirrhosis: A Systematic Review and Meta-analysis. Semin Liver Dis,2019,39:178-194.
[9] de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol,2015,63:743-752.
[10] Pfisterer N, RiedL F, Pachofszky T, et al. Outcomes after placement of a SX-ELLA oesophageal stent for refractory variceal bleeding-A national multicentre study. Liver Int,2019,39:290-298.
[11] Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut,2015,64:1680-1704.
[12] Patidar KR, Sydnor M, Sanyal AJ. Transjugular intrahepatic portosystemic shunt. Clin Liver Dis,2014,18:853-876.
[13] Sengstaken RW, Blakemore AH. Balloon tamponage for the control of hemorrhage from esophageal varices. Ann Surg,1950,131:781-789.
[14] Maiwall R, Jamwal KD, Bhardwaj A, et al. SX-Ella Stent Danis Effectively Controls Refractory Variceal Bleed in Patients with Acute-on-Chronic Liver Failure. Dig Dis Sci,2018,63:493-501.
[15] Hernández-Gea V, Berbel C, Baiges A,et al. Acute variceal bleeding: risk stratification and management (including TIPS). Hepatol Int,2018,12:81-90.
[16] Luz GO, Matuguma SE, Madruga Neto AC, et al. A novel technique in the management of refractory variceal bleeding. Endoscopy,2020,52:310-311.
[17] Lo GH. The use of esophageal stent in controlling acute refractory variceal bleeding. Hepatology,2017,65:385-386.
[18] Escorsell ?, Pavel O, Cárdenas A,et al. Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial. Hepatology,2016,63:1957-1967.
[19] GundLing F, Tiller M, Schepp W. Comment on "esophageal balloon tamponade vs. esophageal stent in controlling acute refractory variceal bleeding: A multicenter RCT". Hepatology,2017,65:2120-2121.